Evidence map›Paper›PMID 29040262›Full record

ArticlePLoS neglected tropical diseases2017

Serological and spatial analysis of alphavirus and flavivirus prevalence and risk factors in a rural community in western Kenya.

Elysse N Grossi-Soyster, Elizabeth A J Cook, William A de Glanville, Lian F Thomas, Amy R Krystosik, Justin Lee, C Njeri Wamae, Samuel Kariuki, Eric M Fèvre, A Desiree LaBeaud

Open access · goldAbstract read
In one paragraph

Article in PLoS neglected tropical diseases, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 39 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
39citing papers in PubMed, 3 pooled it
4.7field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

39 citing papers in PubMed, 3 syntheses or guidelines pooled it, 59 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Chikungunya fever in Africa: a systematic review.Pathogens and global health · 2020
    Pooled it
  4. Article
  5. Article
  6. Predicting the ecological niches ofFrontiers in tropical diseases · 2025
    Article
  7. Temporal Variation and Human Host Predominance inPathogens (Basel, Switzerland) · 2025
    Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Review
  15. Review
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 5 institutions in 3 countries.

Elysse N Grossi-SoysterDepartments of Pediatrics, Infectious Disease Division, Stanford University School of Medicine, Stanford, California, United States of America.ORCID http://orcid.org/0000-0002-2719-1973
Elizabeth A J CookZoonotic and Emerging Diseases Group, International Livestock Research Institute, Nairobi, Kenya.
William A de GlanvilleZoonotic and Emerging Diseases Group, International Livestock Research Institute, Nairobi, Kenya.
Lian F ThomasZoonotic and Emerging Diseases Group, International Livestock Research Institute, Nairobi, Kenya.
Amy R KrystosikDepartments of Pediatrics, Infectious Disease Division, Stanford University School of Medicine, Stanford, California, United States of America.
Justin LeeQuantitative Sciences Unit, Stanford University School of Medicine, Stanford, California, United States of America.
C Njeri WamaeDepartment of Microbiology, School of Medicine, Mount Kenya University, Thika, Kenya.
Samuel KariukiCentre for Microbiology Research, Kenya Medical Research Institute (KEMRI), Nairobi, Kenya.
Eric M FèvreZoonotic and Emerging Diseases Group, International Livestock Research Institute, Nairobi, Kenya.
A Desiree LaBeaudDepartments of Pediatrics, Infectious Disease Division, Stanford University School of Medicine, Stanford, California, United States of America.
Stanford University · USCentre for Immunity, Infection and Evolution · GBKenya Medical Research Institute · KEMount Kenya University · KEUniversity of Liverpool · GB

Funding

The child health impacts of overlapping vector-borne diseases in KenyaR01AI102918 · NIAID · STANFORD UNIVERSITY · PI Angelle Desiree LaBeaud · 2013 to 2026
$7.7M
Biotechnology and Biological Sciences Research Council BB/L019019/1NIAID NIH HHS R01 AI102918Wellcome Trust
6 · The paper itself

Abstract

Alphaviruses, such as chikungunya virus, and flaviviruses, such as dengue virus, are (re)-emerging arboviruses that are endemic in tropical environments. In Africa, arbovirus infections are often undiagnosed and unreported, with febrile illnesses often assumed to be malaria. This cross-sectional study aimed to characterize the seroprevalence of alphaviruses and flaviviruses among children (ages 5-14, n = 250) and adults (ages 15 ≥ 75, n = 250) in western Kenya. Risk factors for seropositivity were explored using Lasso regression. Overall, 67% of participants showed alphavirus seropositivity (CI95 63%-70%), and 1.6% of participants showed flavivirus seropositivity (CI95 0.7%-3%). Children aged 10-14 were more likely to be seropositive to an alphavirus than adults (p < 0.001), suggesting a recent transmission period. Alphavirus and flavivirus seropositivity was detected in the youngest participants (age 5-9), providing evidence of inter-epidemic transmission. Demographic variables that were significantly different amongst those with previous infection versus those without infection included age, education level, and occupation. Behavioral and environmental variables significantly different amongst those in with previous infection to those without infection included taking animals for grazing, fishing, and recent village flooding. Experience of recent fever was also found to be a significant indicator of infection (p = 0.027). These results confirm alphavirus and flavivirus exposure in western Kenya, while illustrating significantly higher alphavirus transmission compared to previous studies.

Indexed as

Rural PopulationAdolescentAdultAgedAged, 80 and overAlphavirusAlphavirus InfectionsAntibodies, ViralChildChild, PreschoolFemaleFlavivirusFlavivirus InfectionsHumansKenyaMaleAntibodies, Viral

Identifiers

PMID29040262
PMCPMC5659799
OpenAlexW2766663244

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.